165 related articles for article (PubMed ID: 18186114)
1. Retinoblastoma: approaching international standards for recommending chemotherapy (Commentary on Chantada et al., page 692).
Meadows AT
Pediatr Blood Cancer; 2008 Mar; 50(3):521-2. PubMed ID: 18186114
[No Abstract] [Full Text] [Related]
2. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.
Chantada GL; Doz F; Orjuela M; Qaddoumi I; Sitorus RS; Kepak T; Furmanchuk A; Castellanos M; Sharma T; Chevez-Barrios P; Rodriguez-Galindo C;
Pediatr Blood Cancer; 2008 Mar; 50(3):692-4. PubMed ID: 18059037
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
Kim JW
Int Ophthalmol Clin; 2015; 55(1):77-96. PubMed ID: 25436495
[No Abstract] [Full Text] [Related]
4. [Retinoblastoma metastatic to the parotid gland: A case report].
Zrafi WS; Kanoun Belajouza S; Mestiri S; Mokni M; Bouaouina N
J Fr Ophtalmol; 2018 Apr; 41(4):e141-e143. PubMed ID: 29655578
[No Abstract] [Full Text] [Related]
5. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
Dimaras H; Khetan V; Halliday W; Héon E; Chan HS; Gallie BL
Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
[No Abstract] [Full Text] [Related]
6. A perspective on chemoreduction and focal therapy for retinoblastoma.
Balasubramanya R; Pushker N; Bajaj MS; Ghose S; Rani A
Am J Ophthalmol; 2002 Oct; 134(4):633; author reply 633-4. PubMed ID: 12383837
[No Abstract] [Full Text] [Related]
7. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
ElZomor H; Taha H; Aleieldin A; Nour R; Zaghloul MS; Fawzi M; Kamel A; Alfaar AS
Ophthalmic Genet; 2015; 36(3):287-9. PubMed ID: 25945688
[No Abstract] [Full Text] [Related]
8. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali.
Boubacar T; Fatou S; Fousseyni T; Mariam S; Fatoumata DT; Toumani S; Abdoul-Aziz D; Marouf KM
Br J Ophthalmol; 2010 Apr; 94(4):467-9. PubMed ID: 19822911
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic changes in retinoblastoma after chemoreduction.
Dithmar S; Aabert TM; Grossniklaus HE
Retina; 2000; 20(1):33-6. PubMed ID: 10696744
[TBL] [Abstract][Full Text] [Related]
10. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
Mathew AA; Sachdev N; Staffieri SE; McKenzie JD; Elder JE
J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
[TBL] [Abstract][Full Text] [Related]
11. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
[TBL] [Abstract][Full Text] [Related]
12. Chemoreduction in the management of retinoblastoma.
Shields JA; Shields CL; Meadows AT
Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
[No Abstract] [Full Text] [Related]
13. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR
Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
[No Abstract] [Full Text] [Related]
14. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
15. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.
Sullivan EM; Wilson MW; Billups CA; Wu J; Merchant TE; Brennan RC; Haik BG; Shulkin B; Free TM; Given V; Rodriguez-Galindo C; Qaddoumi I
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e335-40. PubMed ID: 24577551
[TBL] [Abstract][Full Text] [Related]
16. Residual intraretinal retinoblastoma after chemoreduction failure.
Hwang CK; Aaberg TM; Chevez-Barrios P; Verner-Cole E; Gombos DS; Paysse E; Chintagumpala M; Gao W; Grossniklaus HE
Arch Ophthalmol; 2012 Feb; 130(2):246-8. PubMed ID: 22332223
[No Abstract] [Full Text] [Related]
17. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
20. What is the best treatment for retinoblastoma?
Harbour JW
Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
